Pulmatrix (NASDAQ:PULM) Receives New Coverage from Analysts at StockNews.comTicker Report • 22 days ago
StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM - Free Report) in a research report report published on Sunday morning. The brokerage issued a hold rating on the biotechnology...
Share to Feed
StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM - Free Report) in a report released on Sunday. The firm issued a hold rating on the biotechnology company's stock.
Pulmatrix Stock Up...
Pulmatrix ( NASDAQ:PULM ) Full Year 2023 Results Key Financial Results Revenue: US$7.30m (up 20% from FY 2022). Net...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
PULM stock results show that Pulmatrix beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of...
Pulmatrix GAAP EPS of -$3.87, revenue of $7.3M...
Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update PR Newswire BEDFORD...
Equities research analysts at StockNews.com began coverage on shares of Pulmatrix (NASDAQ:PULM Get Free Report) in a research report issued to clients and investors on Saturday. The firm set...
StockNews.com started coverage on shares of Pulmatrix (NASDAQ:PULM Free Report) in a research note released on Thursday morning. The firm issued a hold rating on the biotechnology...
StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM Free Report) in a research report report published on Wednesday morning. The firm issued a hold rating on the biotechnology...
StockNews.com assumed coverage on shares of Pulmatrix (NASDAQ:PULM Free Report) in a research note published on Sunday. The firm issued a hold rating on the biotechnology companys...